Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.504
+0.004 (0.16%)
Oct 27, 2026, 10:32 AM CET

Oryzon Genomics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
20524591115133142
Market Cap Growth
-18.79%170.69%-21.18%-13.63%-6.58%-32.20%
Enterprise Value
20123299121129124
Last Close Price
2.503.111.401.892.482.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.98106.87---
PS Ratio
13.3022.4312.318.108.4813.42
PB Ratio
1.712.081.031.411.832.00
P/TBV Ratio
1.712.081.031.411.852.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
13.0521.2413.408.538.1911.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.150.180.220.310.25
Net Debt / Equity Ratio
-0.03-0.090.120.070.02-0.16
Net Debt / EBITDA Ratio
0.671.90-2.42-1.36-0.231.63
Net Debt / FCF Ratio
0.784.39-1.83-10.46-0.642.95
Asset Turnover
0.110.090.070.140.160.11
Inventory Turnover
37.7984.2367.1130.808.173.55
Quick Ratio
1.591.940.740.871.343.75
Current Ratio
1.601.950.750.871.343.76
Return on Equity (ROE)
-2.08%-2.53%-4.21%-4.35%-5.88%-6.37%
Return on Assets (ROA)
-2.66%-2.81%-2.60%-2.71%-3.45%-4.63%
Return on Capital Employed (ROCE)
-4.60%-4.40%-4.60%-5.00%-6.50%-8.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.25%-1.06%-3.95%-2.92%-3.18%-3.29%
FCF Yield
-2.44%-0.98%-6.39%-0.50%-1.44%-2.67%
Buyback Yield / Dilution
-0.01%-19.72%-6.35%-10.10%-4.80%-